Blood test may spot hidden cancer early in patients with limited spread
NCT ID NCT07426250
First seen Feb 26, 2026 · Last updated Jun 23, 2026 · Updated 19 times
Summary
This study looks at whether a blood test that detects tumor DNA (ctDNA) can help predict if cancer will come back after local treatment in patients whose cancer has spread to only a few spots. Researchers will follow 500 adults with various solid cancers who are scheduled for local therapy. They will take blood samples before, during, and after treatment to see if ctDNA levels relate to recurrence or survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OLIGOMETASTATIC CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Department of Oncology, Aarhus University Hospital
Aarhus N, 8200, Denmark
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
What this could lead to
If successful, this could show that simple blood tests help doctors detect cancer return earlier and guide treatment decisions for patients with limited spread.
What could go wrong
This is an observational study, not a treatment trial. It will not directly improve outcomes, and results may not apply to all cancer types or treatments.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.